| Nov 25 | Feb 26 | May 26 | Aug 26 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Buy | — | — | — | — | — | — | — | — | — | — | — | — |
| Sell | 3 | — | 6 | 10 | — | 3 | 18 | — | — | — | — | — |
| total | individual payouts | |
|---|---|---|
| 2022 | ‡‡‡ |
|
| 2021 | ‡‡‡ |
|
| 2020 | ‡‡‡ |
|
| 2019 | ‡‡‡ |
|
| 2017 | ‡‡‡ |
|
| 2023 | 2024 | 2025 | Q'26 | |
|---|---|---|---|---|
| Cash | 512.21 | 640.67 | 588.17 | 672.81 |
| Receivables | 194.93 | 200.83 | 195.92 | 187.73 |
| Inventory | 49.96 | 56.53 | 61.77 | 64.75 |
| Other | 28.35 | 33.04 | 44.20 | 49.57 |
| 785.45 | 931.06 | 890.05 | 974.86 |
| 2023 | 2024 | 2025 | Q'26 | |
|---|---|---|---|---|
| Payables | 84.02 | 78.72 | 84.21 | 117.28 |
| ST’ Debt | 6.62 | 17.97 | 0.01 | 3.89 |
| Other | 69.00 | — | — | — |
| 185.22 | 183.81 | 165.87 | 197.28 |
| 10y | 5y | 3y | |
| Sales | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Cash Flow | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Earnings | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Book Value | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Jan | Apr | Jul | Oct | Year | |
|---|---|---|---|---|---|
| ’26 | 225.07 | 209.94 | 216.05 | — |
—
|
| ’25 | 212.14 | 210.99 | 210.39 | 215.77 |
849.29
|
| ’24 | 216.33 | 217.00 | 210.98 | 222.63 |
866.95
|
| ’23 | 211.09 | 229.31 | 224.21 | 227.47 |
892.08
|
| ’22 | 189.83 | 204.51 | 219.95 | 210.27 |
824.55
|
| ’21 | 152.07 | 159.76 | 170.64 | 181.29 |
663.76
|
| ’20 | 159.74 | 142.77 | 157.90 | 149.29 |
609.69
|
| Jan | Apr | Jul | Oct | Year | |
|---|---|---|---|---|---|
| ’26 | 97.25 | 47.03 | 76.33 | — |
—
|
| ’25 | 78.47 | 31.45 | 50.06 | 87.82 |
247.80
|
| ’24 | 41.51 | 76.49 | 75.08 | 68.37 |
261.44
|
| ’23 | 27.68 | 82.00 | 85.88 | 106.62 |
302.18
|
| ’22 | 59.13 | 44.16 | 92.63 | 79.27 |
275.19
|
| ’21 | 26.29 | 31.93 | 54.88 | 37.68 |
150.77
|
| ’20 | 30.79 | 30.54 | 16.94 | 64.78 |
143.05
|
| Jan | Apr | Jul | Oct | Year | |
|---|---|---|---|---|---|
| ’26 | 49.62 | 1.23 | 39.35 | — |
—
|
| ’25 | 43.27 | (29.10) | 25.22 | 20.18 |
59.57
|
| ’24 | (1.81) | 56.49 | 50.66 | 25.07 |
130.41
|
| ’23 | (3.42) | 55.37 | 64.79 | 54.02 |
170.76
|
| ’22 | 39.96 | 28.53 | 81.10 | 13.06 |
162.64
|
| ’21 | 8.76 | (24.05) | 35.92 | 20.71 |
41.50
|
| ’20 | 16.98 | 14.22 | 10.24 | 30.64 |
72.07
|
| Jan | Apr | Jul | Oct | Year | |
|---|---|---|---|---|---|
| ’26 | 0.74 | 0.54 | 0.49 | — |
—
|
| ’25 | 0.68 | 0.15 | 0.39 | 1.07 |
2.28
|
| ’24 | 0.42 | 0.58 | 0.55 | 0.54 |
2.09
|
| ’23 | 0.23 | 0.65 | 0.44 | 0.72 |
2.03
|
| ’22 | 0.38 | 0.49 | 0.51 | 0.60 |
1.94
|
| ’21 | 0.13 | 0.17 | 0.28 | 0.33 |
0.89
|
| ’20 | 0.16 | 0.10 | 0.17 | 0.10 |
0.52
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ‡‡‡ | ‡‡‡‡ | ‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡‡ | 13.87 | 13.86 | 20.25 | 16.46 | — | — | — |
Low Price
|
| ‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡ | 25.81 | 32.60 | 34.16 | 39.80 | — | — | — |
High Price
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 1,828 | 1,885 | 1,878 | 1,908 | — | — | — |
Employees
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 0.45 | 0.47 | 0.46 | 0.45 | — | — | — |
Revenue/Emp
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 824.55 | 892.08 | 866.95 | 849.29 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Revenue
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 35.68% | 37.68% | 36.44% | 35.30% | — | — | — |
Gross Margin
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 239.03 | 269.95 | 247.42 | 221.78 | — | — | — |
EBT
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 28.99% | 30.26% | 28.54% | 26.11% | ‡‡‡ | ‡‡‡ | ‡‡‡ |
EBT Margin
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 179.24 | 199.63 | 183.85 | 190.23 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Net Income
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 80.33 | 80.84 | 82.81 | 77.61 | — | — | — |
Depreciation
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 13.62 | 14.59 | 14.05 | 14.25 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Revenue/Sh
|
| ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡ | 1.96 | 2.05 | 2.12 | 2.29 | ‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡ |
Earnings/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 4.54 | 4.94 | 4.24 | 4.16 | — | — | — |
Cash Flow/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (1.86) | (2.15) | (2.12) | (3.16) | ‡‡‡ | ‡‡‡ | ‡‡‡ |
Capex/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 2.69 | 2.79 | 2.11 | 1.00 | — | — | — |
Free CF/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 17.54 | 20.86 | 23.99 | 26.80 | — | — | — |
Book Value/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 60.56 | 61.14 | 61.73 | 59.61 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Shares
|
| ‡‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 8.15 | 8.96 | 10.70 | 10.35 | ‡‡‡‡ | ‡‡‡‡ | — |
PE Ratio
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 1.19 | 1.26 | 1.62 | 1.68 | ‡‡‡ | ‡‡‡ | ‡‡‡ |
PS Ratio
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 0.92 | 0.88 | 0.95 | 0.89 | ‡‡‡ | ‡‡‡ | ‡‡‡ |
PB Ratio
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 0.81 | 0.71 | 0.91 | 0.98 | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ |
EV/Sales
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 4.10 | 3.73 | 6.04 | 14.14 | — | — | — |
EV/FCF
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 275.19 | 302.18 | 261.44 | 247.80 | ‡‡‡ | ‡‡‡ | ‡‡‡ |
Op' Cash Flow
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (112.54) | (131.41) | (131.03) | (188.23) | — | — | — |
Capex
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 162.64 | 170.76 | 130.41 | 59.57 | — | — | — |
FCF
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 450.86 | 600.23 | 747.25 | 724.18 | — | — | — |
Working Cap'
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 42.33 | 24.62 | 18.00 | 0.02 | — | — | — |
Total Debt
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (316.17) | (487.59) | (622.67) | (588.14) | — | — | — |
Net Debt
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 1,062.09 | 1,275.61 | 1,480.76 | 1,597.31 | — | — | — |
Sh' Equity
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 9.10% | 8.83% | 8.07% | 7.76% | — | — | — |
ROA
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 17.75% | 20.07% | 16.13% | 12.89% | — | — | — |
ROIC
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 11.52% | 10.74% | 9.48% | 8.86% | — | — | — |
ROE
|
Photronics, Inc. (PLAB), a leader in photomask manufacturing essential for semiconductors and flat-panel displays, has demonstrated remarkable resilience through industry cycles, more than doubling revenue from $483 million in 2016 to a projected $849 million in 2025 while boosting revenue per employee 50% via automation and a shift to high-end EUV masks for clients like TSMC and Samsung. This growth rides tailwinds from AI-driven chip complexity, the U.S. CHIPS Act, and global capacity expansions, with gross margins expanding from the low 20s to 35-37% and net income surging 840% to $190 million, alongside peak ROIC of 20.1% and debt slashed 96% to near zero—leaving the firm cash-rich with $588 million net cash.
Free cash flow per share hit $4.94 in 2023, funding buybacks that cut shares 12%, while the stock soared 221% over the decade, tracking profitability peaks amid semi booms. Recent revenue dips (3-5% in 2024-2025) from display inventory corrections have tempered gains, compounded by heavy insider selling ($12.7 million in sells vs. minimal buys), yet analysts forecast a rebound to $946 million revenue by 2027, EPS at $2.22, and 8-9% upside to targets at discounted 10x forward PE and 1.7x PS multiples.
Positioned for AI and EUV tailwinds with diversified global fabs mitigating risks, PLAB offers undervalued semi exposure with robust ROE above 8% and fortress-like balance sheet—despite near-term wobbles, its track record of operational leverage and capital efficiency signals potential for outsized returns in the next upcycle.
Keep track of companies that you follow and research.
Full access to our data with predictions and indicators that we calculate daily.
Full access to our screener with tons of custom values and customizable email notifications.
Excel export of financials and screeners you define and save.